351 related articles for article (PubMed ID: 22972866)
1. Clostridium difficile ribotype does not predict severe infection.
Walk ST; Micic D; Jain R; Lo ES; Trivedi I; Liu EW; Almassalha LM; Ewing SA; Ring C; Galecki AT; Rogers MA; Washer L; Newton DW; Malani PN; Young VB; Aronoff DM
Clin Infect Dis; 2012 Dec; 55(12):1661-8. PubMed ID: 22972866
[TBL] [Abstract][Full Text] [Related]
2.
Azimirad M; Krutova M; Yadegar A; Shahrokh S; Olfatifar M; Aghdaei HA; Fawley WN; Wilcox MH; Zali MR
Emerg Microbes Infect; 2020 Dec; 9(1):1432-1443. PubMed ID: 32520657
[No Abstract] [Full Text] [Related]
3. Clostridium difficile infection in an Iranian hospital.
Jalali M; Khorvash F; Warriner K; Weese JS
BMC Res Notes; 2012 Mar; 5():159. PubMed ID: 22436392
[TBL] [Abstract][Full Text] [Related]
4. An Observational Cohort Study of
Rao K; Higgins PDR; Young VB
mSphere; 2018; 3(3):. PubMed ID: 29794054
[TBL] [Abstract][Full Text] [Related]
5. Ribotyping of Clostridium difficile strains associated with nosocomial transmission and relapses in a Swedish County.
Magnusson C; Wullt M; Löfgren S; Iveroth P; Akerlund T; Matussek A
APMIS; 2013 Feb; 121(2):153-7. PubMed ID: 23030627
[TBL] [Abstract][Full Text] [Related]
6. In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent.
Aitken SL; Alam MJ; Khaleduzzaman M; Walk ST; Musick WL; Pham VP; Christensen JL; Atmar RL; Xie Y; Garey KW
Infect Control Hosp Epidemiol; 2015 Nov; 36(11):1318-23. PubMed ID: 26288985
[TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018.
Spigaglia P; Barbanti F; Dionisi AM; Mastrantonio P
J Clin Microbiol; 2010 Aug; 48(8):2892-6. PubMed ID: 20554809
[TBL] [Abstract][Full Text] [Related]
8. Emergence of Clostridium difficile ribotype 027 in Korea.
Kim H; Lee Y; Moon HW; Lim CS; Lee K; Chong Y
Korean J Lab Med; 2011 Jul; 31(3):191-6. PubMed ID: 21779194
[TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality.
Rao K; Micic D; Natarajan M; Winters S; Kiel MJ; Walk ST; Santhosh K; Mogle JA; Galecki AT; LeBar W; Higgins PD; Young VB; Aronoff DM
Clin Infect Dis; 2015 Jul; 61(2):233-41. PubMed ID: 25828993
[TBL] [Abstract][Full Text] [Related]
10. Detection of mixed populations of Clostridium difficile from symptomatic patients using capillary-based polymerase chain reaction ribotyping.
Behroozian AA; Chludzinski JP; Lo ES; Ewing SA; Waslawski S; Newton DW; Young VB; Aronoff DM; Walk ST
Infect Control Hosp Epidemiol; 2013 Sep; 34(9):961-966. PubMed ID: 23917911
[TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile ribotype 176 - A predictor for high mortality and risk of nosocomial spread?
Polivkova S; Krutova M; Petrlova K; Benes J; Nyc O
Anaerobe; 2016 Aug; 40():35-40. PubMed ID: 27155489
[TBL] [Abstract][Full Text] [Related]
12. Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008.
Ilchmann C; Zaiss NH; Speicher A; Christner M; Ackermann G; Rohde H
Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1571-3. PubMed ID: 20632051
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiology of severe Clostridium difficile infections in Hesse, Germany in 2008-2009].
Arvand M; Hauri AM; Zaiss NH; Witte W; Bettge-Weller G
Dtsch Med Wochenschr; 2010 Oct; 135(40):1963-7. PubMed ID: 20922636
[TBL] [Abstract][Full Text] [Related]
14. Two-year analysis of Clostridium difficile ribotypes associated with increased severity.
Herbert R; Hatcher J; Jauneikaite E; Gharbi M; d'Arc S; Obaray N; Rickards T; Rebec M; Blandy O; Hope R; Thomas A; Bamford K; Jepson A; Sriskandan S
J Hosp Infect; 2019 Dec; 103(4):388-394. PubMed ID: 31220480
[TBL] [Abstract][Full Text] [Related]
15. Use of highly discriminatory fingerprinting to analyze clusters of Clostridium difficile infection cases due to epidemic ribotype 027 strains.
Fawley WN; Freeman J; Smith C; Harmanus C; van den Berg RJ; Kuijper EJ; Wilcox MH
J Clin Microbiol; 2008 Mar; 46(3):954-60. PubMed ID: 18216211
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile isolates with increased sporulation: emergence of PCR ribotype 002 in Hong Kong.
Cheng VC; Yam WC; Lam OT; Tsang JL; Tse EY; Siu GK; Chan JF; Tse H; To KK; Tai JW; Ho PL; Yuen KY
Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1371-81. PubMed ID: 21468685
[TBL] [Abstract][Full Text] [Related]
17. Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains.
Almutairi MS; Gonzales-Luna AJ; Alnezary FS; Fallatah SB; Alam MJ; Begum K; Garey KW
Anaerobe; 2021 Dec; 72():102440. PubMed ID: 34461273
[TBL] [Abstract][Full Text] [Related]
18. Polymerase chain reaction ribotyping of Clostridium difficile isolates in Qatar: a hospital-based study.
Al-Thani AA; Hamdi WS; Al-Ansari NA; Doiphode SH; Wilson GJ
BMC Infect Dis; 2014 Sep; 14():502. PubMed ID: 25223337
[TBL] [Abstract][Full Text] [Related]
19. Outbreak of Clostridium difficile PCR ribotype 027--the recent experience of a regional hospital.
Oleastro M; Coelho M; Gião M; Coutinho S; Mota S; Santos A; Rodrigues J; Faria D
BMC Infect Dis; 2014 Apr; 14():209. PubMed ID: 24739945
[TBL] [Abstract][Full Text] [Related]
20. Molecular, microbiological and clinical characterization of Clostridium difficile isolates from tertiary care hospitals in Colombia.
Salazar CL; Reyes C; Atehortua S; Sierra P; Correa MM; Paredes-Sabja D; Best E; Fawley WN; Wilcox M; González Á
PLoS One; 2017; 12(9):e0184689. PubMed ID: 28902923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
